Chloroquine, a cheap drug used in Africa for decades to cure malaria may be able treat COVID-19, a study published in Nature has found.
The study found that “remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro.”
“Early evidence suggests that chloroquine — an inexpensive anti-malarial drug — may work just as well, if not even better, than remdesivir, a drug owned by Gilead, which is undergoing clinical trials for treatment of the coronavirus,” Axios said.
In a scoop on Wednesday, Axios quoted a senior Health and Human Services official and another source as confirming that Pharma company Bayer will soon make a large donation to the U.S. government of a drug that has shown some promise in helping patients suffering from the novel coronavirus.
The report acknowledged that the world was still a very long way from having an approved, clinically tested treatment for the coronavirus, adding that it did not hurt to have a potential treatment on hand.